NCT00647296 is a 2 part, randomized, double-blind, safety and tolerability study evaluating the drug KNS-760704 in patients with amyotrophic lateral sclerosis (ALS). The drug KNS-760704 is now known as dexpramipexole. Other study ID includes: KNS-760704-CL201.
Advice & Tips:
This Clinical Trial is to evaluate the tolerabiltiy and effectiveness of an investigational drug. Initially a double blind placebo-controlled study, the research is now in an open-label phase where I know I am taking the active compound. The research results are not yet known . Personally I can't tell if it has slowed the progression of symptoms since I have never had ALS before! The burden of this treatment involves traveling over 100 miles every month or two to the research site, for EKG, blood work, urinalysis, two spinal taps, physical exams, medication logs,and other requirements of the research protocol.
< $25 monthly
Showing 1 of 1 patient evaluation for ALS Phase 2 Study KNS-760704 CL201